ICICI Direct is bullish on Mphasis has recommended buy rating on the stock with a target price of Rs 930 in its research report dated May 14, 2020.
ICICI Direct's research report on Mphasis
Mphasis reported a healthy set of Q4FY20 numbers. The company reported 1.5% QoQ growth in revenue in constant currency mainly led by 2.7% QoQ growth in direct international business partly offset by 1% QoQ fall in HP/DXC channel. Operating margin rose 10 bps to 16.3% while operating profit rose 3.7% QoQ. Net profit grew 20.3% QoQ to Rs 353 crore, mainly led by lower tax and higher other income. The company declared a dividend of Rs 35/share. Mphasis has won $201 million of TCV in direct international of which 79% of deal wins is in new generation services business.
As most deal wins by the company have higher proportion of digital business, we expect accelerated growth in medium term. Further, healthy balance sheet could help the company in inorganic revenue growth opportunities. This coupled with healthy capital allocation prompt us to upgrade the stock from HOLD to BUY with a revised target price of Rs 930 (13x FY22E EPS).
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.